SCHEMBL3943459

SCHEMBL3943459

N#CNc1cccc(-c2cs[c]n2)c1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 1/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ HTT P42858 3/20 0.33
▸ KMT2A Q03164 5/20 0.32
▸ MEN1 O00255 4/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ MAPT P10636 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ PDE4D Q08499 1/20 0.32
▸ OTUD7B Q6GQQ9 1/20 0.31
▸ JAK2 O60674 1/20 0.31
▸ JAK3 P52333 1/20 0.31
▸ HPGD P15428 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ CTSS P25774 4/20 0.30
▸ CTSK P43235 4/20 0.30
▸ PDE4B Q07343 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3947270 0.81 PLK1 (0.40) CNR1HTTKMT2AMEN1ALDH1A1
SCHEMBL11507047 0.76 HSD17B1 (0.49) HTTKMT2AMEN1ALDH1A1MAPT
SCHEMBL17626272 0.75 HTT (0.60) HTTALDH1A1MAPK1SMN1; SMN2JAK2
SCHEMBL17626118 0.75 MAPT (0.35) HTTKMT2AMEN1ALDH1A1MAPT
SCHEMBL3949513 0.73 ADRA2A (0.43) ALDH1A1MAPTSMN1; SMN2
SCHEMBL7228532 0.72 RAB9A (0.51) KMT2AMEN1ALDH1A1MAPTSMN1; SMN2
SCHEMBL468087 0.72 CYP19A1 (0.45) MAPTMAPK1SMN1; SMN2CTSSCTSK
SCHEMBL6050957 0.72 KDM4E (0.51) KMT2AMEN1ALDH1A1MAPT
SCHEMBL1915009 0.72 IDO1 (0.45) KMT2AMEN1ALDH1A1MAPTSMN1; SMN2
SCHEMBL4711911 0.72 RECQL (0.50) KMT2AMEN1ALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2010508-A1 THIAZOL-GUANIDINE DERIVATIVES USEFUL AS A (BETA)- RELATED PATHOLOGIES AstraZeneca AB (SE) 2009-01-07 — — EP claimed
WO-2007120096-A1 THIAZOL-GUANIDINE DERIVATIVES USEFUL AS A (BETA)- RELATED PATHOLOGIES ASTRAZENECA AB (SE) 2007-10-25 — — WO claimed
EP-2010508-A1 THIAZOL-GUANIDINE DERIVATIVES USEFUL AS A (BETA)- RELATED PATHOLOGIES AstraZeneca AB (SE) 2009-01-07 — — EP disclosed
WO-2007120096-A1 THIAZOL-GUANIDINE DERIVATIVES USEFUL AS A (BETA)- RELATED PATHOLOGIES ASTRAZENECA AB (SE) 2007-10-25 — — WO disclosed
Send feedback